Anzeige
Mehr »
Login
Montag, 03.10.2022 Börsentäglich über 12.000 News von 678 internationalen Medien
Early-Bird-Gelegenheit!? – Die große Gewinnchance am Tag der Deutschen Einheit!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von PMLiVE

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
16.09.Pfizer's investigational meningococcal vaccine shows promise in phase 3 trial
16.09.Neuron23 and QIAGEN partner to develop companion diagnostic for Parkinson's disease
15.09.The value of patient reported outcomes
15.09.FDA and NIHR launch public-private partnership for rare neurodegenerative diseases
15.09.Pfizer doses first patients with mRNA-based influenza vaccine
15.09.Novavax's COVID-19 vaccine candidate receives EC approval for use as a booster
15.09.WHO/Europe urges member states to endorse cervical cancer elimination roadmap
15.09.Locus Biosciences announces first patient treated in urinary tract infection trial
15.09.Havas Health & You appoints Laura Mizrahi as chief creative officer of H4B Chelsea
14.09.Thriving, not surviving - a hybrid mentality
14.09.Novartis announces $300m investment to boost development of next-generation biotherapeutics
14.09.WHO announces new global fund for pandemic prevention and preparedness
14.09.CuraSen Therapeutics doses first patients with novel combination therapy in dementia study
14.09.AstraZeneca's Imfinzi plus chemotherapy shows promise for advanced biliary tract cancer
13.09.Creating strong employee engagement and retaining talent in the new normal
13.09.Pfizer/BioNTech BA.4/BA.5 COVID-19 booster receives CHMP recommendation
13.09.Novartis and BeiGene announce positive phase 3 trial results for hepatocellular carcinoma treatment
13.09.AstraZeneca and Daiichi Sankyo's Enhertu shows significant improvements for lung cancer patients
13.09.Regeneron's fianlimab/Libtayo combination shows positive results in advanced melanoma treatment
12.09.Building a brighter future with patient support programmes
12.09.The benefits of patient support programmes in specific disease areas
12.09.AstraZeneca's shares positive Tagrisso data in patients with EGFR-mutated lung cancer
12.09.Regeneron's Libtayo shows promising results in phase 2 skin cancer trial
12.09.Amgen announces positive results for Lumakras colorectal cancer combination treatment
12.09.OPEN Health appoints Stephen Chick as chief growth officer for Evidence & Access